Endocarditis
Drug research and approvals for endocarditis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 17, 2026, 37 studies of endocarditis are recruiting on ClinicalTrials.gov, Health Canada has authorized 1 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.
- Recruiting worldwide: 37
- Trials authorized in Canada: 1
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 37 recruiting on ClinicalTrials.gov ↗- A Prospective Diagnostic Trial of Al[¹⁸F]F-NOTA-folate PET in Patients With Suspected Cardiac Sarcoidosis and Infective…NCT07814222 · Not applicable · Turku University Hospital · starts Sep 14, 2026
- Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve…NCT07345325 · Phase 3 · Nantes University Hospital · starts Jun 11, 2026
- Anemia Therapy in Patients With Infective EndocarditisNCT07523646 · Phase 4 · Copenhagen University Hospital, Rigshospitalet · starts May 15, 2026
- The Study Tests if Preoperative Dental Screening is Superior to no Preoperative Dental Screening in Improving the…NCT07511673 · Not applicable · Region Skane · starts May 6, 2026
- From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus…NCT07313865 · Not applicable · University Hospital, Clermont-Ferrand · starts Apr 17, 2026
- Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus BacteremiaNCT06650488 · Phase 4 · Todd C. Lee MD MPH FIDSA · starts Feb 23, 2026
- Evaluation of the Benefits of Hypnosis During Transoesophageal EchocardiographyNCT07512830 · Not applicable · Fondation Hôpital Saint-Joseph · starts Feb 18, 2026
- Etiologic Diagnosis Algorithm in Infective EndocarditisNCT07682389 · Not applicable · I.M. Sechenov First Moscow State Medical University · starts Jan 20, 2026
- Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus BacteremiaNCT06650501 · Phase 4 · McGill University Health Centre/Research Institute of the McGill University Health Centre · starts Jan 15, 2026
- Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3NCT06457386 · Not applicable · Assistance Publique - Hôpitaux de Paris · starts May 14, 2025
Drug Pipeline
6 approved, 3 in phase 3, 3 in phase 2; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Vancomycin, Daptomycin, Cilastatin, Cefazolin, Ampicillin, Imipenem anhydrous
- Rifampin
- Phase 3 Bacterial DNA-directed RNA polymerase inhibitor
- Amoxicillin
- Phase 3 Bacterial penicillin-binding protein inhibitor
- Levofloxacin anhydrous
- Phase 3 DNA gyrase inhibitor
- Ceftriaxone
- Phase 2 Bacterial penicillin-binding protein inhibitor
- Oxygen
- Phase 2 Essential for cellular homeostasis
- Gallium citrate
- Phase 2
How Its Trials Ended
162 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 27 whose ending is known, 19% met their primary endpoint, 15% missed it and 67% stopped early.
- Ongoing5534%
- Completed, result not reported4528%
- Status unknown3522%
- Stopped: other or unclear74%
- Stopped: enrollment or feasibility64%
- Met its primary endpoint53%
- Missed its primary endpoint42%
- Stopped: lack of efficacy32%
- Stopped: sponsor or business decision11%
- Stopped: funding11%
Trials Authorized in Canada
Newest first; search them all in Canada trials| Authorized | Trial | Sponsor | Status |
|---|---|---|---|
| Aug 2, 2024 | Adjunctive rifampin for the treatment of prosthetic valve endocarditis due to s. aureus (rifa-snap)Rifampin | Research Institute Of The Mcgill University Health Centre | Closed |
FDA Orphan Designations
Approved first, then open designations, newest first| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Jun 10, 2024 | CalpurbatugTreatment of infective endocarditis | Trellis Bioscience Inc. | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA